ArticleThe journal of allergy and clinical immunology. Global2025

Omalizumab controls surface phenotypes of dendritic cells and monocytes in asthma.

Agnes Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.